Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease demyelinating disease
Phenotype C0035435|rheumatic diseases
Sentences 2
PubMedID- 22152489 Conclusions: it is not clear whether tnf antagonists increase the incidence of demyelinating diseases in patients with rheumatic diseases.
PubMedID- 20864146 Objectives: to estimate the rate of demyelinating diseases in patients with rheumatic diseases treated with tumor necrosis factor (tnf) antagonists and to describe the cases reported to 3 different pharmacovigilance sources.

Page: 1